Showing results (691-700 of 798) with videos related to
Sort By:
Pageof 80
Pharmaceutical Research|December 29, 2023
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig ModelManfred Bodenlenz, Thean Yeoh, Gabriel Berstein, et al.Human Vaccines & Immunotherapeutics|May 13, 2025
Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individualsBruce K Patterson, Ram Yogendra, Edgar B Francisco, et al.Cancer Research|August 15, 2008
Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivoYihong Zhang, Paula J Kaplan-Lefko, Karen Rex, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|January 29, 2019
Early Mechanistic Events Induced by Low Molecular Weight Polycyclic Aromatic Hydrocarbons in Mouse Lung Epithelial Cells: A Role for Eicosanoid SignalingKatelyn J Siegrist, DeeDee Romo, Brad L Upham, et al.Spine|May 5, 2026
Revisiting Survival in the Treatment of Spinal Metastases from Lung Cancer in the Modern Era of Immunotherapy and Molecular Targeted Treatment (2017-2022)Brendan M Striano, Marco L Ferrone, Kaitlyn E Holly, et al.Physical Review Letters|September 3, 2021
Quantum-Well Bound States in Graphene Heterostructure InterfacesZhongwei Dai, Zhaoli Gao, Sergey S Pershoguba, et al.Molecular and Cellular Biochemistry|December 24, 1997
Effect of short-term treatment with a monoclonal antibody to P-selectin on balloon catheter-induced: intimal hyperplasia, re-endothelialization, and attenuation of endothelial-dependent relaxationD L Akers, D J Lefer, I L Chen, et al.The Lancet. Oncology|October 17, 2021
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysisJennifer J Gao, Joyce Cheng, Tatiana M Prowell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2023
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast CancerPreeti Narayan, Asma Dilawari, Christy Osgood, et al.The British Journal of Ophthalmology|June 27, 2022
Novel ophthalmic findings and deep phenotyping in Williams-Beuren syndromeLaryssa A Huryn, Taylor Flaherty, Rosalie Nolen, et al.Pageof 80